Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SRC | P12931 | 3/20 | 0.42 |
| ▸ | ABL1 | P00519 | 1/20 | 0.42 |
| ▸ | PDGFRB | P09619 | 1/20 | 0.42 |
| ▸ | KIT | P10721 | 1/20 | 0.42 |
| ▸ | PDGFRA | P16234 | 1/20 | 0.42 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.42 |
| ▸ | SYK | P43405 | 1/20 | 0.41 |
| ▸ | CDK1 | P06493 | 2/20 | 0.38 |
| ▸ | CCNB1 | P14635 | 2/20 | 0.38 |
| ▸ | CCNT1 | O60563 | 1/20 | 0.38 |
| ▸ | CDK7 | P50613 | 1/20 | 0.38 |
| ▸ | CDK9 | P50750 | 1/20 | 0.38 |
| ▸ | CCNH | P51946 | 1/20 | 0.38 |
| ▸ | KDM1A | O60341 | 1/20 | 0.37 |
| ▸ | CDK4 | P11802 | 4/20 | 0.37 |
| ▸ | CCND1 | P24385 | 4/20 | 0.37 |
| ▸ | CCND2 | P30279 | 4/20 | 0.37 |
| ▸ | CCND3 | P30281 | 4/20 | 0.37 |
| ▸ | GSK3A | P49840 | 2/20 | 0.37 |
| ▸ | GSK3B | P49841 | 2/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3586411 | 0.91 | SRC (0.40) | SRCABL1PDGFRBKITPDGFRA | |
| SCHEMBL3589735 | 0.84 | GSK3B (0.53) | GSK3AGSK3BEGFR | |
| SCHEMBL3588854 | 0.84 | PDGFRB (0.47) | SRCPDGFRBPDGFRASYKCDK4 | |
| SCHEMBL3585927 | 0.82 | STAT6 (0.53) | SRCPDGFRBPDGFRASYKCDK1 | |
| SCHEMBL3590227 | 0.82 | MAPK10 (0.49) | PDGFRASYKCDK4CCND1CCND2 | |
| SCHEMBL3587383 | 0.82 | DCLK1 (0.39) | SRCCDK1CCNB1CCNT1CDK7 | |
| SCHEMBL3588808 | 0.81 | CDK4 (0.54) | KDM1ACDK4CCND1CCND2CCND3 | |
| SCHEMBL3573049 | 0.81 | CDK1 (0.46) | CDK1CCNB1CCNT1CDK7CDK9 | |
| SCHEMBL3571516 | 0.81 | EGFR (0.56) | SRCPDGFRBPDGFRACDK1CCNB1 | |
| SCHEMBL3581836 | 0.81 | CDK4 (0.49) | KITCDK4CCND1CCND2CCND3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100190787-A1 | Modulators of Mitotic Kinases | BIOGEN IDEC MA INC | 2010-07-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100190787-A1 | Modulators of Mitotic Kinases | CDK1, BUB1, BUB1B | SRC 295/4885ABL1 374/4885PDGFRB 2901/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.